APOTEX is an independent, dynamic pharmaceutical company committed to R&D, manufacturing and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers and governments worldwide.
We will always meet global regulatory, quality and compliance requirements. We value and respect our employees, our business partners, our suppliers, our customers and the communities we serve while operating with accountability and integrity in everything we do.
Apotex Inc. was founded in 1974 in Canada, and the company has grown to employ over 6,500 people in research, development, manufacturing and distribution facilities world-wide. Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats. Today, Apotex is a necessary and trusted member of the global healthcare community. The company's pharmaceuticals can be found in pharmacy and healthcare facilities in over 115 countries around the globe. Apotex has established a presence through subsidiaries, joint ventures or licensing agreements in Australia, Belgium, Czech Republic, Mexico, Netherlands, New Zealand, Poland, Turkey, and the UK, to name just a few. Healthcare professionals around the world rely on Apotex for quality and value.
Although the company's own business is developing and manufacturing generic pharmaceuticals, the success of Apotex has enabled it to diversify into a number of other health-related areas. The Apotex Pharmaceutical Group of Companies also researches, develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics for medical use. The worldwide sales of the Apotex Group of companies exceed $2 billion (AUD $) per year.Learn more about Apotex
Apotex in Australia
Improved patient outcomes and easing the burden on healthcare systems worldwide is what drives us in everything we do. Apotex Pty Ltd is the Australian subsidiary of the Apotex Group of Companies. Apotex’s commitment to improving access to quality, affordable medicines has meant Australians have been able to access generic versions of essential medicines such as rosuvastatin, clopidogrel, perindopril, leflunomide and mometasone sooner.
Apotex supports the business and profession of pharmacy in Australia by maintaining a robust product portfolio across retail prescription, hospital, over-the-counter (OTC) and vitamins, minerals and supplements (VMS), a strong pipeline and focus on first-to-market launches, innovative and best-in-class professional services and training, and significant business partnerships across products and services.For more healthcare professional information